Cardiotoxicity After Synthetic Cathinone Use; Two Cases, A Case Series and Scoping Review
-
Published:2024-02-27
Issue:3
Volume:24
Page:209-224
-
ISSN:1530-7905
-
Container-title:Cardiovascular Toxicology
-
language:en
-
Short-container-title:Cardiovasc Toxicol
Author:
Groenewegen K. L.,Gresnigt F. M. J.,Lonkhuyzen J. J. Nugteren-van,den Haan C.,Franssen E. J. F.,Riezebos R. K.,Ohana D.,de Lange D. W.
Abstract
AbstractThe cardiotoxic effects of synthetic cathinones remain largely unknown. In this study, we present two cases, a case series and a scoping review, to explore synthetic cathinone associated cardiotoxicity. Case 1 involved a 28-year-old male with non-ST-elevation myocardial infarction after ingesting a substance containing 4-methylmethcathinone (4-MMC), 3-methylmethcathinon (3-MMC), and methcathinone. Case 2 involved a 49-year-old male with ventricular fibrillation after 4-methylmethcathinone ingestion, who was diagnosed with severe three-vessel disease. A retrospective analysis was performed on self-reported synthetic cathinone poisonings reported to the Dutch Poisons Information Centre from 2012 to 2022. A total of 222 mono-intoxications with cardiotoxicity were included, mostly involving 3-methylmethcathinon (63%). Often tachycardia, hypertension, palpitations, and chest pain were reported. A comprehensive literature search was performed on PubMed to identify the studies reporting cardiac arrest, myocardial infarction, cardiac inflammation, cardiomyopathy, and life-threatening arrhythmias following synthetic cathinone use. A total of 30 articles reporting 40 cases were included. The reported complications included cardiac arrest (n = 28), ventricular tachycardia (n = 4), supraventricular tachycardia (n = 1), ST-elevation myocardial infarction (n = 2), non-ST-elevation myocardial infarction (n = 2), cardiomyopathy (n = 1), and myocarditis (n = 2). A total of ten different associated synthetic cathinones were identified. Cardiac arrest, myocardial infarction, and ventricular arrhythmias have been reported following the use of synthetic cathinones, underscoring the importance of obtaining a detailed recreational drug use history from patients presenting with syncope, chest pain, or palpitations.
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Silva, B., Soares, J., Rocha-Pereira, C., Mladěnka, P., Remião, F., Researchers, O. B. O. T. O. (2022). Khat, a cultural chewing drug: A toxicokinetic and toxicodynamic summary. Toxins. https://doi.org/10.3390/toxins14020071 2. Simmons, S. J., Leyrer-Jackson, J. M., Oliver, C. F., Hicks, C., Muschamp, J. W., Rawls, S. M., & Olive, M. F. (2018). DARK classics in chemical neuroscience: Cathinone-derived psychostimulants. ACS Chemical Neuroscience, 9(10), 2379–2394. https://doi.org/10.1021/acschemneuro.8b00147 3. Wojcieszak, J., Kuczyńska, K., & Zawilska, J. B. (2020). Four synthetic cathinones: 3-chloromethcathinone, 4-chloromethcathinone, 4-fluoro-α-pyrrolidinopentiophenone, and 4-methoxy-α-pyrrolidinopentiophenone produce changes in the spontaneous locomotor activity and motor performance in mice with varied profile. Neurotoxicity Research, 38(2), 536–551. https://doi.org/10.1007/s12640-020-00227-8 4. Loftis, J. M., & Janowsky, A. (2014). Neuroimmune basis of methamphetamine toxicity. International Review of Neurobiology, 118, 165–197. https://doi.org/10.1016/B978-0-12-801284-0.00007-5 5. Riley, A. L., Nelson, K. H., To, P., López-Arnau, R., Xu, P., Wang, D., Wang, Y., Shen, H.-W., Kuhn, D. M., Angoa-Perez, M., Anneken, J. H., Muskiewicz, D., & Hall, F. S. (2020). Abuse potential and toxicity of the synthetic cathinones (i.e., ‘Bath salts’). Neuroscience and Biobehavioral Reviews, 110, 150–173. https://doi.org/10.1016/j.neubiorev.2018.07.015
|
|